相关实验视频

Updated: May 22, 2025

Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue

Engineered 3D Silk-collagen-based Model of Polarized Neural Tissue

Published on: October 23, 2015

对于中枢神经系统药物发现和设计的分子生成

Shengneng Chen¹, Ding Luo¹, Weiwei Xue¹

¹School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China.

ACS chemical neuroscience

|March 13, 2025

概括

生成型人工智能 (GenAI) 提供了设计药物的新方法. 这种观点探讨使用专门的GenAI模型来创建可以穿越血脑屏障 (BBB) 的中枢神经系统 (CNS) 药物,以更好地发现药物.

科学领域:

计算化学是一种计算化学.
人工智能在药物发现中的作用
神经科学是一个神经科学.

背景情况:

生成型人工智能 (GenAI) 正在推动药物设计.
设计中枢神经系统 (CNS) 药物面临挑战,包括穿越血脑屏障 (BBB).
对于中枢神经系统药物发现的GenAI的应用尚未得到充分探索.

研究的目的:

探索GenAI在设计中枢神经系统药物的潜力.
突出中枢神经系统类似药物的特性和数据资源的重要性.
倡导针对中枢神经系统药物发现的专门GenAI模型.

主要方法:

在药物设计中审查当前的GenAI技术.
讨论中枢神经系统类似药物的特性和相关数据集.
建议将GenAI与实验数据和评估指标集成在一起.

主要成果:

基因人工智能可以成为探索中枢神经系统中类似药物的化学空间的强大工具.
需要专门的GenAI模型来解决BBB透率和中枢神经系统药物的向参与.
将GenAI与实验数据集成可以提高中枢神经系统药物发现效率.

结论:

基因人工智能对加速新型中枢神经系统疗法的发现具有重大前景.
开发有针对性的GenAI策略对于克服中枢神经系统药物设计障碍至关重要.
对专门的GenAI模型的进一步研究可以解锁治疗神经系统疾病的新可能性.

关键词:

血脑屏障血脑屏障是什么?中枢神经系统中枢神经系统药物设计药物设计生成性AI是一种人工智能.

更多相关视频

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods

Published on: November 19, 2019

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...